24 / 116
22
Pharmaceuticals & Intermediates
Products
API Intermediates APIs Others
Sales increased on the back of non-
pharma products and from higher sales
of API intermediates. The new API
intermediates introduced in the recent
times are exhibiting a promising future.
The products made by the Division are
used mainly by Pharmaceutical and
Aerospace Industries. These Industries
have so far shown that they are able to
sustain margins and in turn are in a
position to offer better prices for the
products they buy. The competitors are
based in China, India and in other
countries.
The Division is backward integrated and
possesses good infrastructure. It has the
ability to meet the emerging needs of the
customers. The Division is a new entrant
in Pharmaceutical Industry and has still to
establish itself in terms of reputation and
size. There are immense opportunities,
and it is expected to grow rapidly in
the near future. Since the products in
Pharmaceutical Industry require several
statutory approvals, it is possible that
some of them may not get
commercialised.
2007-08
2008-09
% change over 2007-08
Operating revenues (Rs crores)
67
74
12
Contribution to total operating revenues (%)
7
6
(1)